X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (342) 342
Paper (74) 74
Publication (65) 65
Report (29) 29
Patent (26) 26
Newspaper Article (9) 9
Book Chapter (3) 3
Book Review (2) 2
Data Set (2) 2
Conference Proceeding (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (111) 111
oncology (101) 101
experiment (81) 81
index medicus (81) 81
particle physics (74) 74
physics - high energy physics - experiment (69) 69
high energy physics - experiment (68) 68
cern lhc coll (66) 66
female (66) 66
physics (66) 66
experimental results (65) 65
cancer (58) 58
middle aged (56) 56
male (55) 55
high energy physics (51) 51
aged (49) 49
p p: scattering (45) 45
hep (44) 44
adult (41) 41
p p: colliding beams (40) 40
chemotherapy (37) 37
phenomenology (33) 33
13000 gev-cms (29) 29
medicine & public health (28) 28
atlas (27) 27
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (25) 25
anemia (24) 24
breast cancer (23) 23
treatment outcome (23) 23
analysis (22) 22
prospective studies (22) 22
quality-of-life (22) 22
scattering [p p] (22) 22
colliding beams [p p] (21) 21
aged, 80 and over (20) 20
care and treatment (19) 19
nuclear experiment (19) 19
neoplasms - drug therapy (18) 18
8000 gev-cms (17) 17
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (17) 17
electricity (17) 17
expression (17) 17
neoplasms - complications (17) 17
epoetin-alpha (16) 16
physics of elementary particles and fields (16) 16
conversion or distribution of electric power (15) 15
dynamo-electric machines (15) 15
generation (15) 15
hematology (15) 15
medicine (15) 15
research (15) 15
transverse momentum dependence (15) 15
granulocyte colony-stimulating factor (14) 14
patients (14) 14
quality of life (14) 14
antineoplastic agents - adverse effects (13) 13
antineoplastic agents - therapeutic use (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
double-blind (13) 13
filgrastim (13) 13
health aspects (13) 13
hemoglobin (13) 13
neutropenia (13) 13
anemia - drug therapy (12) 12
hadron-hadron scattering (12) 12
health care sciences & services (12) 12
mass dependence (12) 12
risk factors (12) 12
spain (12) 12
activation (11) 11
animals (11) 11
astrophysics (11) 11
background (11) 11
breast neoplasms - drug therapy (11) 11
hematinics - therapeutic use (11) 11
mortality (11) 11
pain medicine (11) 11
prognosis (11) 11
studies (11) 11
survival (11) 11
therapy (11) 11
anemia - etiology (10) 10
antibodies, monoclonal, humanized (10) 10
apoptosis (10) 10
biological products (10) 10
breast neoplasms - pathology (10) 10
differential cross section: measured (10) 10
ecology (10) 10
erythropoiesis-stimulating agents (10) 10
kinematics (10) 10
numerical calculations: monte carlo (10) 10
nursing (10) 10
particle physics - experiment (10) 10
prevalence (10) 10
rapidity dependence (10) 10
biosimilar (9) 9
breast-cancer (9) 9
cancer patients (9) 9
cern lab (9) 9
colony-stimulating factor (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell Reports, ISSN 2211-1247, 02/2014, Volume 6, Issue 3, pp. 514 - 527
Journal Article
Therapeutic Advances in Hematology, ISSN 2040-6207, 12/2015, Volume 6, Issue 6, pp. 267 - 281
The loss of patents covering many biopharmaceutical/biological agents in the mid 1990s led to the introduction of a new generation of drugs: biosimilars. These... 
hematopoietic growth factors | biosimilars | monoclonal antibodies | Reviews
Journal Article
Targeted Oncology, ISSN 1776-2596, 3/2012, Volume 7, Issue S1, pp. 29 - 34
Journal Article
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2013, Volume 88, Issue 3, pp. 625 - 636
Journal Article
European Journal of Haematology, ISSN 0902-4441, 03/2018, Volume 100, Issue 3, pp. 241 - 246
Objective Prospective data on the use of granulocyte‐colony‐stimulating factor (G‐CSF) in non‐Hodgkin's lymphoma and its aggressive subtypes, including diffuse... 
socio‐economics and ethics | supportive care | non‐Hodgkin's lymphoma | non-Hodgkin's lymphoma | socio-economics and ethics | ADULT PATIENTS | MULTICENTER | COLONY-STIMULATING FACTOR | EORTC GUIDELINES | SOLID TUMORS | SINGLE-ADMINISTRATION PEGFILGRASTIM | INDUCED FEBRILE NEUTROPENIA | BREAST-CANCER | B-CELL LYMPHOMA | NON-HODGKINS-LYMPHOMA | HEMATOLOGY | Back Pain - chemically induced | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Myeloablative Agonists - adverse effects | Back Pain - physiopathology | Febrile Neutropenia - chemically induced | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Arthralgia - physiopathology | Arthralgia - chemically induced | Febrile Neutropenia - prevention & control | Bone and Bones - drug effects | Back Pain - prevention & control | Patient Safety | Adult | Female | Filgrastim - therapeutic use | Arthralgia - prevention & control | Febrile Neutropenia - physiopathology | Biosimilar Pharmaceuticals - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Hematologic Agents - therapeutic use | Treatment Outcome | Bacterial Infections - prevention & control | Bone and Bones - physiopathology | Myeloablative Agonists - administration & dosage | Aged | Neoplasm Staging | Anti-Bacterial Agents - administration & dosage | Medical research | Chemotherapy | Granulocyte colony-stimulating factor | Analysis | Medicine, Experimental | Lymphomas | Drug therapy | Backache | Business ethics | Neutropenia | Cancer | Pain | Lymphocytes B | Arthralgia | Prophylaxis | Colony-stimulating factor | Non-Hodgkin's lymphoma | Leukocytes (granulocytic) | B-cell lymphoma
Journal Article
The FEBS Journal, ISSN 1742-464X, 10/2014, Volume 281, Issue 19, pp. 4450 - 4466
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 2/2016, Volume 24, Issue 2, pp. 911 - 925
Journal Article